stockrowUFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) Shares outstanding
UFP Technologies, Inc.'s shares outstanding at the end of fiscal 2025 was $7.8M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $7.8M. Over the past ten years it has ranged from $7.2M (fiscal 2015) to $7.8M (fiscal 2025) — the current reading is the highest in ten years. UFP Technologies, Inc. ranks 117th of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $7.8M | 0.24% |
| FY2024 | $7.8M | 1.09% |
| FY2023 | $7.7M | 0.50% |
| FY2022 | $7.7M | 0.63% |
| FY2021 | $7.6M | 0.62% |
| FY2020 | $7.6M | 0.69% |
| FY2019 | $7.5M | 1.16% |
| FY2018 | $7.4M | 1.27% |
| FY2017 | $7.3M | 0.85% |
| FY2016 | $7.3M | 0.96% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $7.8M | 0.23% |
| Jun 2026 | $7.8M | (0.14%) |
| Mar 2026 | $7.8M | (0.06%) |
| Dec 2025 | $7.8M | 0.31% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BFLY Butterfly Network, Inc. compare | $266.5M |
| NEOG Neogen Corporation compare | $218.1M |
| NVCR NovoCure Limited compare | $116.8M |
| ALMR Alamar Biosciences, Inc. compare | $69.1M |
| AXGN AxoGen, Inc. compare | $61.5M |
| TMDX TransMedics Group, Inc. compare | $40.8M |
| ESTA Establishment Labs Holdings Inc. compare | $30.1M |
| INSP Inspire Medical Systems, Inc. compare | $28.9M |
| UFPT UFP Technologies, Inc. | $7.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement